Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis.

Thiruppathi M, Rowin J, Ganesh B, Sheng JR, Prabhakar BS, Meriggioli MN.

Clin Immunol. 2012 Dec;145(3):209-23. doi: 10.1016/j.clim.2012.09.012. Epub 2012 Oct 7.

2.

Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.

Mohammadnia-Afrouzi M, Zavaran Hosseini A, Khalili A, Abediankenari S, Hosseini V, Maleki I.

Autoimmunity. 2015;48(8):556-61. doi: 10.3109/08916934.2015.1070835. Epub 2015 Aug 31.

PMID:
26333292
3.

The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.

Zhang Y, Wang HB, Chi LJ, Wang WZ.

Immunol Lett. 2009 Jan 29;122(1):52-7. doi: 10.1016/j.imlet.2008.11.015. Epub 2008 Dec 25.

PMID:
19111574
4.

Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.

Yu Y, Miller J, Leventhal JR, Tambur AR, Chandrasekaran D, Levitsky J, Luo X, Mathew JM.

PLoS One. 2011;6(7):e22450. doi: 10.1371/journal.pone.0022450. Epub 2011 Jul 22.

6.

Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.

Huang S, Wang W, Chi L.

BMC Neurol. 2015 Sep 7;15:163. doi: 10.1186/s12883-015-0419-9.

7.
8.

Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.

Xu WH, Zhang AM, Ren MS, Zhang XD, Wang F, Xu XC, Li Q, Wang J, Din BS, Wu YB, Chen GH.

J Clin Immunol. 2012 Oct;32(5):975-83. doi: 10.1007/s10875-012-9685-0. Epub 2012 Mar 31.

PMID:
22467037
9.

Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.

Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, Foti M, Berrih-Aknin S.

J Autoimmun. 2014 Aug;52:53-63. doi: 10.1016/j.jaut.2013.12.015. Epub 2014 Jan 7.

PMID:
24405842
10.

Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.

Masuda M, Matsumoto M, Tanaka S, Nakajima K, Yamada N, Ido N, Ohtsuka T, Nishida M, Hirano T, Utsumi H.

J Neuroimmunol. 2010 Aug 25;225(1-2):123-31. doi: 10.1016/j.jneuroim.2010.03.016. Epub 2010 May 15.

PMID:
20472307
11.

CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.

Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.

PMID:
19153062
12.

Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.

Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM.

Arthritis Rheum. 2008 Jul;58(7):2120-30. doi: 10.1002/art.23556.

13.

Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.

Bossowski A, Moniuszko M, Dąbrowska M, Sawicka B, Rusak M, Jeznach M, Wójtowicz J, Bodzenta-Lukaszyk A, Bossowska A.

Autoimmunity. 2013 May;46(3):222-30. doi: 10.3109/08916934.2012.751981. Epub 2013 Jan 22.

PMID:
23249428
14.

Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis.

Walter GJ, Fleskens V, Frederiksen KS, Rajasekhar M, Menon B, Gerwien JG, Evans HG, Taams LS.

Arthritis Rheumatol. 2016 Jan;68(1):103-16. doi: 10.1002/art.39408.

15.

Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.

Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

16.

Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.

Mayer E, Bannert C, Gruber S, Klunker S, Spittler A, Akdis CA, Szépfalusi Z, Eiwegger T.

PLoS One. 2012;7(1):e29355. doi: 10.1371/journal.pone.0029355. Epub 2012 Jan 17.

17.

Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.

18.

Feedback loop of immune regulation by CD4+CD25+ Treg.

Jung YJ, Seoh JY.

Immunobiology. 2009;214(4):291-302. doi: 10.1016/j.imbio.2008.09.004. Epub 2008 Nov 1.

PMID:
19327546
19.

CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.

Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, Dominguez-Villar M, Hafler DA.

J Immunol. 2011 Mar 15;186(6):3317-26. doi: 10.4049/jimmunol.1002502. Epub 2011 Feb 7.

20.

Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.

Pan XD, Mao YQ, Zhu LJ, Li J, Xie Y, Wang L, Zhang GB.

Chin Med J (Engl). 2012 Jun;125(11):2004-11.

PMID:
22884069

Supplemental Content

Support Center